[Federal Register Volume 73, Number 78 (Tuesday, April 22, 2008)]
[Notices]
[Page 21630]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: E8-8617]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Centers for Disease Control and Prevention


Disease, Disability, and Injury Prevention and Control Special 
Emphasis Panel (SEP): Evaluation of the Validity of Coverage Survey 
Self-Reported Audit Vaccination Status, Funding Opportunity 
Announcement (FOA) IP08-003; Strategies to Extend the Influenza 
Vaccination Season in Medical Practices, IP08-004; Effectiveness of a 
Hospital-Based Program for Vaccination of Birth Mothers and Household 
Contacts with Influenza Vaccines and Combined Tetanus Toxoid and a 
Cellular Pertussis Vaccine, FOA IP08-005; Effectiveness of an 
Intervention to Promote a Targeted Vaccination Program in the 
Obstetrician-Gynecologist Setting, FOA IP08-008

    In accordance with Section 10(a)(2) of the Federal Advisory 
Committee Act (Pub. L. 92-463), the Centers for Disease Control and 
Prevention (CDC) announces the aforementioned meeting:

    Time and Date: 12 p.m.-4 p.m., May 20, 2008 (Closed).
    Place: Teleconference.
    Status: The meeting will be closed to the public in accordance 
with provisions set forth in Section 552b(c)(4) and (6), Title 5 
U.S.C., and the Determination of the Director, Management Analysis 
and Services Office, CDC, pursuant to Public Law 92-463.
    Matters to be Discussed: The meeting will include the review, 
discussion, and evaluation of ``Evaluation of the Validity of 
Coverage Survey Self-Reported Audit Vaccination Status, FOA IP08-
003; Strategies to Extend the Influenza Vaccination Season in 
Medical Practices, FOA IP08-004; Effectiveness of a Hospital-Based 
Program for Vaccination of Birth Mothers and Household Contacts with 
Influenza Vaccines and Combined Tetanus Toxoid and a Cellular 
Pertussis Vaccine, FOA IP08-005; Effectiveness of an Intervention to 
Promote a Targeted Vaccination Program in the Obstetrician-
Gynecologist Setting, FOA IP08-008.''
    Contact Person for More Information: Sheree Marshall Williams, 
Ph.D., Scientific Review Administrator, CDC, 1600 Clifton Road, NE., 
Mailstop D72, Atlanta, GA 30333, Telephone: (404) 639-4896.
    The Director, Management Analysis and Services Office, has been 
delegated the authority to sign Federal Register notices pertaining 
to announcements of meetings and other committee management 
activities, for both CDC and the Agency for Toxic Substances and 
Disease Registry.

    Dated: April 15, 2008.
Elaine L. Baker,
Director, Management Analysis and Services Office, Centers for Disease 
Control and Prevention.
[FR Doc. E8-8617 Filed 4-21-08; 8:45 am]
BILLING CODE 4163-18-P